Blog
RSS FeedPosted by Michael Wonder on 20 May 2019
FDA's strengthened global inspection program helps ensure generic drug safety
17 May 2019 - Consumers must have confidence in the safety and quality of generic medicines. ...
Posted by Michael Wonder on 13 May 2019
Japan health ministry orders Ono Pharmaceutical to add warning to Opdivo cancer drug after death
10 May 2019 - The health ministry said Thursday that a patient taking the cancer drug Opdivo has died and ...
Posted by Michael Wonder on 10 May 2019
Allegations of widespread fraud raise questions about the safety of generic drugs made overseas
10 May 2019 - It is something we've all heard before: generic drugs are the same as brand-name drugs. They ...
Posted by Michael Wonder on 07 May 2019
Working together for safe medicines in the EU
6 May 2019 - EMA launches a social media campaign to highlight how the European medicines regulatory network keeps medicines ...
Posted by Michael Wonder on 25 Apr 2019
When prescribing cures for 'overpriced' drugs, Government's first duty is do no harm
25 April 2019 - Overpriced. Excessive. Escalating. Gouging. ...
Posted by Michael Wonder on 14 Apr 2019
Use of multiple sclerosis medicine Lemtrada restricted while EMA review is ongoing
12 April 2019 - EMA has started a review of the multiple sclerosis medicine Lemtrada (alemtuzumab) following new reports of ...
Posted by Michael Wonder on 27 Mar 2019
New EudraVigilance system improves reporting of side effects and detection of safety signals
27 March 2019 - The new and improved EudraVigilance, the European system for managing and analysing information on suspected adverse ...
Posted by Michael Wonder on 07 Mar 2019
Many local governments shrug off FDA warning about Canadian drug imports
7 March 2019 - Cities and local governments in several states said they will continue to use a Canadian company ...
Posted by Michael Wonder on 12 Feb 2019
Statement from FDA Commissioner on ongoing efforts to stop the spread of illicit opioids, further secure the U.S. drug supply chain and forcefully confront opioid epidemic
12 February 2019 - The opioid epidemic continues to be one of the greatest challenges facing this nation and the FDA. ...
Posted by Michael Wonder on 11 Feb 2019
Fake drugs could put patients at risk after no-deal Brexit
8 February 2019 - Patients could be put at risk from fake medicines if the UK exits the EU without ...
Posted by Michael Wonder on 08 Feb 2019
New safety features for medicines sold in the EU
8 February 2019 - As of 9 February 2019, most prescription medicines and some over-the-counter medicines for human use supplied ...
Posted by Michael Wonder on 08 Feb 2019
FDA takes new steps to adopt more modern technologies for improving the security of the drug supply chain through innovations that improve tracking and tracing of medicines
7 February 2019 - A key element of the U.S. FDA’s mission is focused on helping to ensure that all ...
Posted by Michael Wonder on 05 Feb 2019
Risk classification of antimicrobials used in animals opens for public consultation
5 February 2019 - EMA has published today for public consultation its updated scientific advice on the categorisation of antimicrobials. ...
Posted by Michael Wonder on 24 Jan 2019
FDA statement from Commissioner announcing efforts to improve the quality of the information used to assess the effectiveness of REMS programs in supporting the safe use of medications
24 January 2019 - In making decisions about whether the benefits of a drug outweighs its risks, there are many ...
Posted by Michael Wonder on 17 Jan 2019
FDA issues letter about paclitaxel coated balloons and eluting stents
17 January 2019 - Today the FDA issued a letter to health care providers about a recent publication in the Journal ...